Akanocure Pharmaceuticals Overview
- Founded
-
2015
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$50K
- Investors
-
4
Akanocure Pharmaceuticals General Information
Description
Developer of anti-cancer chemotherapeutic drugs designed to treat various forms of cancer. The company's drugs focus on the synthesis and development of bio-targeted anti-cancer chemotherapeutics derived from natural resources, enabling doctors to treat the side effects of chemotherapy and cancer treatment.
Contact Information
Website
www.akanocure.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
- Purdue Research Park, Ross Enterprise Center
- 3495 Kent Avenue, Suite E-100
- West Lafayette, IN 47906
- United States
Akanocure Pharmaceuticals Timeline
Akanocure Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Grant | 01-Jul-2021 | $50K | 00000 | Completed | Generating Revenue | |
| 11. Grant | 08-Feb-2021 | 0000 | 00000 | Completed | Generating Revenue | |
| 10. Grant | 01-Jan-2021 | 00000 | 00000 | Completed | Generating Revenue | |
| 9. Grant | 29-Apr-2020 | 00000 | 00000 | Completed | Generating Revenue | |
| 8. Grant | 01-Jul-2018 | 0000 | 00000 | Completed | Generating Revenue | |
| 7. Grant | 24-Jan-2018 | 00000 | 00000 | Completed | Generating Revenue | |
| 6. Early Stage VC | 15-Aug-2017 | 0000 | 00000 | Completed | Generating Revenue | |
| 5. Angel (individual) | 01-Aug-2017 | 0000 | 00000 | Completed | Generating Revenue | |
| 4. Early Stage VC | 01-Aug-2016 | $60K | $160K | Completed | Generating Revenue | |
| 3. Accelerator/Incubator | 05-Jun-2015 | $100K | $100K | Completed | Generating Revenue |
Akanocure Pharmaceuticals Patents
Akanocure Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10851121-B2 | Scalable polypropionate lactone stereotetrads | Active | 09-Dec-2016 | 0000000000 | |
| US-20210277032-A1 | Scalable polypropionate lactone stereotetrads | Active | 09-Dec-2016 | 0000000000 | |
| US-11447509-B2 | Scalable polypropionate lactone stereotetrads | Active | 09-Dec-2016 | 0000000000 | 0 |
| CA-3046358-A1 | Scalable polypropionate lactone stereotetrads | Pending | 09-Dec-2016 | 0000000000 | |
| EP-3551615-A4 | Scalable polypropionate lactone stereotetrads | Pending | 09-Dec-2016 | C07F7/1804 | 0 |
Akanocure Pharmaceuticals Executive Team (5)
Akanocure Pharmaceuticals Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Chris Seybold | Founder.org | Board Member | 000 0000 |
| John Bamforth Ph.D | Akanocure Pharmaceuticals | Chairman | 000 0000 |
| Philip Fuchs Ph.D | Akanocure Pharmaceuticals | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 |
| Sherine Abdelmawla Ph.D | Akanocure Pharmaceuticals | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Akanocure Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Akanocure Pharmaceuticals Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| National Science Foundation | Government | 000 0000 | 000000 0 | ||
| Purdue Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Founder.org | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| Elevate Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |